Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,728 public trials 585 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Completed

Assessing the Patient Experience in Cancer Care

NCT01621295

Conditions
Brain Diseases, Brain Neoplasm, Brain Neoplasms, +44 more
Locations
  • Los Angeles County Hospital Los Angeles, California, United States
  • University of Southern California - Norris Los Angeles, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients

NCT01333293

Conditions
Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +4 more
Locations
  • University Hospital Berne (Insel) and Zieglerspital Berne Bern, Switzerland
  • Geneva University Hospitals and Medical Faculty of the University of Geneva Geneva, Switzerland
  • Allergy Unit, Department of Dermatology, University Hospital Zurich Zurich, Switzerland
View Trial Details
Completed

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata

NCT01156857

Conditions
Leiomyoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • Medical University Graz, department of obstetrics and gynecology Graz, Austria
  • Medical University Vienna, department of obstetrics and gynecology Vienna, Austria
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • CHR de la citadelle Liège, Belgium
View all 23 locations
View Trial Details
Completed

Phase 2 Study for the Treatment of Superficial Lipomas

NCT00608842

Conditions
Lipoma, Neoplasms, Neoplasms by Histologic Type, +2 more
Locations
  • Gary D. Monheit, M.D. Birmingham, Alabama, United States
  • Stacy R. Smith San Diego, California, United States
  • Steven Grekin, D.O. Warren, Michigan, United States
  • Joel Schlessinger, M.D. Omaha, Nebraska, United States
View Trial Details
Completed

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study)

NCT01252069

Conditions
Leiomyoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • Medical University Vienna, department of obstetrics and gynecology Vienna, Austria
  • Cliniques Universitaires Saint-Luc Gynécologie-Obstétrique Brussels, Belgium
  • CHR de la Citadelle Gynécologie-Obstétrique Liège, Belgium
  • Cliniques Universitaires UCL de Mont-Godinne Gynécologie-Obstétrique Yvoir, Belgium
View all 18 locations
View Trial Details
Completed

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata

NCT01642472

Conditions
Leiomyoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • Medical University Vienna Vienna, Austria
  • Cliniques Universitaires Saint-Luc, Gynécologie-Obstétrique, Brussels, Belgium
  • CHR de la Citadelle Liège, Belgium
  • Cliniques Universitaires UCL de Mont-Godinne Yvoir, Belgium
View all 16 locations
View Trial Details
Completed

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

NCT00080873

Conditions
Bone Marrow Diseases, Burkitt Lymphoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +56 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Stanford Comprehensive Cancer Center at Stanford University Medical Center Stanford, California, United States
View all 44 locations
View Trial Details
Completed

A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies

NCT00699517

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +1 more
Locations
  • Investigational Site Number 840004 Santa Monica, California, United States
  • Investigational Site Number 840003 Orlando, Florida, United States
  • Investigational Site Number 840005 Maywood, Illinois, United States
  • Investigational Site Number 840002 Newark, New Jersey, United States
View all 45 locations
View Trial Details

Related conditions